Antitumor and cytotoxic effects of Phyllanthus polyphyllus on ehrlich ascites carcinoma and human cancer cell lines

Bioscience, Biotechnology and Biochemistry

Volumn 71, Issue 9, 2007, Pages 2177-2183

  Rajkapoor, Balasubramanian ^a   Sankari, Marimuthu ^a   Sumithra, Mohan ^a   Anbu, Jayaraman ^a   Harikrishnan, Narayanaswamy ^a   Gobinath, Manavalan ^b   Suba, Venkatesan ^a   Balaji, Ramachandran ^c  

^a VELS INSTITUTE OF SCIENCE   (India)

^b Rao's College of Pharmacy   (India)

^c DR M G R EDUCATIONAL AND RESEARCH INSTITUTE   (India)

Author keywords

Antioxidants; Cytotoxic; Ehrlich ascites carcinoma; Life span; Phyllanthus polyphyllus

Indexed keywords

CELLS; CYTOTOXICITY; ENZYMES; LIPIDS; LIVING SYSTEMS STUDIES; METHANOL; ONCOLOGY;

ANTIOXIDANT ENZYMES; CYTOTOXIC ACTIVITY; LIPID PEROXIDATION (LPO); PHYLLANTHUS POLYPHYLLUS;

TUMORS;

ANTIOXIDANT; PLANT EXTRACT;

ANIMAL; ARTICLE; CHEMISTRY; DRUG EFFECT; DRUG SCREENING; EHRLICH ASCITES TUMOR; HUMAN; LIPID PEROXIDATION; MALE; METABOLISM; MOUSE; PATHOLOGY; PHYLLANTHUS; PHYTOTHERAPY; SURVIVAL RATE; TIME; TUMOR CELL LINE;

ANIMALS; ANTIOXIDANTS; CARCINOMA, EHRLICH TUMOR; CELL LINE, TUMOR; HUMANS; LIPID PEROXIDATION; MALE; MICE; PHYLLANTHUS; PHYTOTHERAPY; PLANT EXTRACTS; SURVIVAL RATE; TIME FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS; PHYLLANTHUS POLYPHYLLUS;

EID: 36148999444     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.70149     Document Type: Article

References (49)

1. Kapadia, G. J., Azuine, M. A., Takayasu, J., Konoshima, T., Takasaki, M., and Nishino, H., Inhibition of Epstein-Barr virus early antigen activation promoted by 12-O-tetradecanoylphobol-13-acetate by nonsteroidal anti-inflammatory drugs. Cancer Lett., 161, 221-229 (2000).
2. Kellof, G. J., Perspective on cancer chemoprevention research and drug development. Adv. Cancer Res., 78, 199-334 (2000).
3. Cragg, G. M., Kingston, D. G. I., and Newman, D. J., "Anticancer Agents from Natural Products," Taylor and Francis Group, Brunner-Routledge Psychology Press, London (2005).
4. Newman, D. J., Cragg, G. M., and Snader, K. M., Natural products as a source of new drugs over the period 1981-2002. J. Nat. Prod., 66, 1022-1037 (2003).
5. Kaufman, P. B., Leland, J., Warber, C. S., James, A., Harry, D., and Brielmann, L., "Natural Products from Plants," CRC Press, London, pp. 1581-1589 (1999).
6. DeFeudis, F. V., Papadopoulos, V., and Drieu, K., Ginkgo biloba extracts and cancer: a research area in its infancy. Fun. Clin. Pharmacol., 17, 405-417 (2003).
7. Takeoka, G. R., and Dao, L. T., Antioxidant constituent of almond [Prunus dulcis (Mill.) D. A. Webb.] hulls. J. Agric. Food Chem., 51, 496-501 (2003).
8. Gamble, J. S., "Flora of the Presidency of Madras" Vol 2, Bhishan Singh and Mahindrapal Singh, New Delhi, pp. 1285-1288 (1993).
9. Mathew, K. M., "The Flora of the Tamilnadu Carnatic" Vol 3, The Rapinet Herbarium, St. Joseph's College, Trichirapalli, p. 1468 (1983).
10. Rao, Y. K., and Fang, S. H., Antiinflammatory activities constituents isolated from Phylanthus polyphyllus. J. Ethnopharmacol., 103, 183-186 (2006).
11. Youkwan, J., Srisomphot, P., and Sutthivaiyakit, S., Bioactive constituents of the leaves of Phyllanthus polyphyllus var. siamensis. J. Nat. Prod., 68, 1006-1009 (2005).
12. Rajeshkumar, N. V., Joy, K. L., Kuttan, G., Ramsewak, R. S., Nair, M. G., and Kuttan, R. J., Antitumor and anticarcinogenic activity of Phyllanthus amarus extract. J. Ethnopharmacol., 81, 17-22 (2002).
13. Huang, S. T., Yang, R. C., Lee, P. N., Yang, S. H., Liao, S. K., Chen, T. Y., and Pang, J. H., Antitumor and antiangiogenic effects of Phyllanthus urinaria in mice bearing Lewis lung carcinoma. Int. Immunopharmacol., 6, 870-879 (2006).
14. Tuchinda, P., Kumkao, A., Pohmakotr, M., Sophasan, S., Santisuk, T., and Reutrakul, V., Cytotoxic arylnaphthalide lignan glycosides from the aerial parts of Phyllanthus taxodiifolius. Planta Med., 72, 60-62 (2006).
15. Zhang, Y. J., Nagao, T., Tanaka, T., Yang, C. R., Okabe, H., and Kouno, I., Antiproliferative activity of the main constituents from Phyllanthus emblica. Biol. Pharm. Bull., 27, 251-255 (2004).
16. The Organization of Economic Co-Operation and Development (OECD). The OECD Guideline for Testing of Chemicals: 420 Acute Oral Toxicity, OECD, Paris, pp. 1-14 (2001).
17. Gothoskar, S. V., and Ranadive, K. J., Anticancer screening of SAN-AB: an extract of marking nut Semicarpus anacardium. Indian J. Exp. Biol., 9, 372-375 (1971).
18. Majumdar, U. K., Gupta, M., and Maiti, S., Antitumor activity of Hygrophila spinosa on Ehrlich ascites carcinoma and sarcoma-180 induced mice. Indian J. Exp. Biol., 35, 473-477 (1997).
19. D'Amour, F. F., Blood, F. R., and Belden, D. A., "The Manual for Laboratory Work in Mammalian Physiology," The University of Chicago Press, Chicago, pp. 148-150 (1965).
20. Lowry, O. H., Rosenbrough, N. T., and Farr, A. L., Protein measurement with Folin-Phenol reagent. J. Biol. Chem., 173, 265-275 (1951).
21. Docie, J. V., "Practical Hematology," J&A Churchill Ltd., London, pp. 38-42 (1958).
22. Devasagayam, T. P. A., and Tarachand, U., Decreased lipid peroxidation in the rat kidney during gestation. Biochem. Biophys. Res. Commun., 56, 836-842 (1987).
23. Marklund, S., and Marklund, G., Involvement of superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem., 47, 469-474 (1974).
24. Sinha, A. K., Colorimetric assay of catalase. Anal. Biochem., 47, 389-394 (1972).
25. Rotruck, J. T., Pope, A. L., Ganther, H. L., and Swanson, A. B., Selenium: biochemical role as a component of glutathione peroxidase. Science, 179, 588-590 (1973).
26. Habig, W. H., Pabst, M. J., and Jakoby, W. B., Glutathione S-transferase, the first enzymatic step in mercapturic acid formation. J. Biol. Chem., 249, 7130-7139 (1974).
27. Ramnath, V., Kuttan, G., and Kuttan, R., Cytotoxic and antitumor activity of Abrin on transplanted tumours in mice. Indian J. Physiol. Pharmacol., 46, 69-77 (2002).
28. Sheeja, K. R., Kuttan, G., and Kuttan, R., Cytotoxic and antitumor activity of Berberin. Amala Res. Bull., 17, 73-76 (1997).
29. Scudiero, D. A., Shoemaker, R. H., and Paul, K. D., Evaluation of soluble tetrazolium formazan assay for cell growth and drug sensitivity in cultures using human and other tumour cell lines. Cancer Res., 48, 4827-4833 (1988).
30. Clarkson, B. D., and Burchenal, J. H., Preliminary screening of antineoplastic drugs. Prog. Clin. Cancer, 1, 625-629 (1965).
31. Oberling, C., and Guerin, M., The role of viruses in the production of cancer. Adv. Cancer Res., 2, 353-423 (1954).
32. Marklund, S. L., Westman, N. G., Lundgren, E., and Roos, G., Copper and zinc containing superoxide dismutase, manganese containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues. Cancer Res., 42, 1955-1961 (1982).
33. Price, V. E., and Greenfield, R. E., Anemia in cancer. Adv. Cancer Res., 5, 199-200 (1958).
34. Hogland, H. C., Hematological complications of cancer chemotherapy. Semin. Oncol., 9, 95-102 (1982).
35. Fenninger, L. D., and Mider, G. B., Energy and nitrogen metabolism in cancer. Adv. Cancer Res., 2, 229-253 (1954).
36. Yagi, K., Lipid peroxides and human diseases. Chem. Physiol. Lip., 45, 337-351 (1991).
37. Sinclair, A. J., Barnett, A. H., and Lunie, J., Free radical and auto-oxidant systems in health and disease. Br. J. Hosp. Med., 43, 334-344 (1990).
38. Sun, Y., Oberley, L. W., Elwell, J. H., and Sierra Rivera, E., Antioxidant enzyme activities in normal and transformed mice liver cells. Int. J. Cancer, 44, 1028-1033 (1989).
39. Jiau-Jian, L., and Larry, W. O., Overexpression of manganese-containing superoxide dismutase confers resistance to the cytotoxicity of tumor necrosis factor α and/or hyperthermia. Cancer Res., 57, 1991-1998 (1977).
40. Ruby, A. J., Kuttan, G., Babu, K. D., Rajasekharan, K. N., and Kuttan, R., Antitumor and antioxidant activity of natural curcuminoids. Cancer Lett., 94, 783-799 (1995).
41. Ming, L., Jill, C. P., Jingfang, J. N., Edward, C., and Brash, E., Antioxidant action via p53 mediated apoptosis. Cancer Res., 58, 1723-1729 (1998).
42. Putul, M., Sunit, C., and Pritha, B., Neovascularisation offers a new perspective to glutamine-related therapy. Indian J. Exp. Biol., 38, 88-90 (2000).
43. Ravid, A., and Korean, R., The role of reactive oxygen species in the anticancer activity of vitamin D. Anticancer Res., 164, 357-367 (2003).
44. Feng, Q., Kumangai, T., Torii, Y., Nakamura, Y., Osawa, T., and Uchida, K., Anticarcinigenic antioxidants as inhibitors against intracellular oxidative stress. Free Rad. Res., 35, 779-788 (2001).
45. Suffness, M., and Pezzuto, J. M., Assays related to cancer drug discovery. In "Methods in Plant Biochemistry: Assays for Bioactivity" Vol. 6, ed. Hostettmann, K., Academic Press, London, pp. 71-133 (1990).
46. Brown, J. P., A review of the genetic effect of occurring flavonoids, anthraquinones and related compounds. Mutat. Res., 75, 243-277 (1980).
47. Hirano, T., Oka, K., and Akiba, M., Antiproliferative effect of synthetic and naturally occurring flavonoids on tumour cells of human carcinoma cell lines. Res. Comm. Chem. Path. Pharmacol., 64, 69-78 (1989).
48. Weber, G., Shen, F., and Yeh, Y. A., Increased signal transduction activity and down regulation in human cancer cells. Anticancer Res., 16, 3271-3273 (1996).
49. Fotis, T., Pepper, M. S., Aktan, E., and Breit, S., Flavonoids, dietary derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res., 57, 2916-2918 (1977).